Research programme: cardiometabolic disease theraputics - Moonwalk Biosciences
Alternative Names: cardiometabolic disease theraputics - Moonwalk BiosciencesLatest Information Update: 28 Oct 2024
At a glance
- Originator Moonwalk Biosciences
- Class Cardiovascular therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders; Metabolic disorders